Octagon Capital Advisors LP — 13F Holdings

2026 Q3  ·  29 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Octagon Capital Advisors LP maintained a portfolio of 29 distinct positions. The most significant new addition was OBSIDIAN THERAPEUTICS INC, now representing 4.42% of the total fund value. They heavily accumulated shares in ARRIVENT BIOPHARMA INC, increasing the position by 8.6%. Conversely, Octagon Capital Advisors LP completely exited their position in ALUMIS INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
29
Quarter
2026 Q3
Top Holding
DNTH (19.8%)
Top 10 Concentration
82.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-29 of 29

Octagon Capital Advisors LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
DNTH
DIANTHUS THERAP...
Healthcare 19.79% 16.14% #1
Prev: #1
6.5
—
-155,000 -8.4%
P
S
1,686,667 $148,511,029 2023 Q3 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 13.10% 11.89% #2 1
Prev: #3
6.5
—
no change no change
P
S
993,000 $98,326,860 2025 Q2 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 12.73% 12.47% #3 1
Prev: #2
5.5
—
-439,000 -14.9%
P
S
2,511,000 $95,568,660 2026 Q1 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 10.02% 8.17% #4
Prev: #4
5.5
—
no change no change
P
S
2,350,000 $75,247,000 2024 Q3 13F Filing 2026-09-30 2026-11-16
AVBP
ARRIVENT BIOPHA...
Healthcare 8.64% 6.15% #5 1
Prev: #6
6.0
—
170,333 8.6%
P
S
2,141,387 $64,841,198 2024 Q1 13F Filing 2026-09-30 2026-11-16
TSHA
TAYSHA GENE THE...
Healthcare 6.29% 5.93% #6 1
Prev: #7
3.5
—
no change no change
P
S
9,693,244 $47,206,098 2020 Q4 13F Filing 2026-09-30 2026-11-16
OBX
OBSIDIAN THERAP...
Healthcare 4.42% — #7
Prev: #—
5.3
—
2,414,610 —
NEW
2,414,610 $33,152,595 2026 Q3 13F Filing 2026-09-30 2026-11-16
KYMR
KYMERA THERAPEU...
Healthcare 3.05% 3.20% #8 2
Prev: #10
1.2
—
-105,000 -33.9%
P
S
205,000 $22,916,950 2021 Q2 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 2.35% 1.78% #9 7
Prev: #16
1.9
—
no change no change
P
S
270,000 $17,674,200 2023 Q2 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 2.09% — #10
Prev: #—
4.3
—
630,000 —
NEW
630,000 $15,718,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
XENE
XENON PHARMACEU...
Healthcare 2.08% 2.66% #11 1
Prev: #12
1.3
—
-70,000 -14.3%
P
S
420,000 $15,619,800 2026 Q1 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 1.99% 0.97% #12 7
Prev: #19
1.8
—
no change no change
P
S
934,716 $14,955,456 2026 Q2 13F Filing 2026-09-30 2026-11-16
MIRM
MIRUM PHARMACEU...
Healthcare 1.93% 3.57% #13 4
Prev: #9
0.8
—
-169,450 -50.0%
P
S
169,450 $14,484,586 2022 Q3 13F Filing 2026-09-30 2026-11-16
AKTS
AKTIS ONCOLOGY ...
Healthcare 1.85% 2.78% #14 3
Prev: #11
0.7
—
-247,847 -25.8%
P
S
713,000 $13,882,110 2026 Q1 13F Filing 2026-09-30 2026-11-16
PALI
PALISADE BIO IN...
Healthcare 1.85% 1.93% #15 1
Prev: #14
1.7
—
no change no change
P
S
10,276,317 $13,873,028 2025 Q4 13F Filing 2026-09-30 2026-11-16
N/A
ERASCA INC
CALL
CALL Option 1.41% 2.07% #16 3
Prev: #13
0.6
—
-535,000 -42.6%
P
S
720,000 $10,555,200 — 13F Filing 2026-09-30 2026-11-16
BIOA
BIOAGE LABS INC
Healthcare 1.23% 3.85% #17 9
Prev: #8
0.5
—
-448,000 -25.6%
P
S
1,300,000 $9,217,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 1.05% 1.42% #18
Prev: #18
0.4
—
-207,721 -45.5%
P
S
249,000 $7,898,280 2024 Q3 13F Filing 2026-09-30 2026-11-16
GYRE
GYRE THERAPEUTI...
Healthcare 0.93% 0.57% #19 4
Prev: #23
1.4
—
no change no change
P
S
954,416 $6,995,869 2026 Q2 13F Filing 2026-09-30 2026-11-16
DBVT
DBV TECHNOLOGIE...
Healthcare 0.90% 0.85% #20 1
Prev: #21
1.4
—
no change no change
P
S
574,200 $6,752,592 2025 Q2 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 0.61% 1.83% #21 6
Prev: #15
0.2
—
-1,475,100 -71.1%
P
S
599,900 $4,601,233 2024 Q1 13F Filing 2026-09-30 2026-11-16
TRVI
TREVI THERAPEUT...
Healthcare 0.60% 0.53% #22 2
Prev: #24
1.2
—
no change no change
P
S
315,000 $4,510,800 2025 Q1 13F Filing 2026-09-30 2026-11-16
SNSE
FAETH THERAPEUT...
Healthcare 0.40% 0.81% #23 1
Prev: #22
0.2
—
-261,010 -72.3%
P
S
100,000 $2,974,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
DTIL
PRECISION BIOSC...
Healthcare 0.36% 0.95% #24 4
Prev: #20
0.1
—
-920,000 -68.1%
P
S
430,000 $2,691,800 2025 Q4 13F Filing 2026-09-30 2026-11-16
UNCY
UNICYCIVE THERA...
Healthcare 0.17% 0.42% #25
Prev: #25
0.1
—
-725,000 -72.5%
P
S
275,000 $1,291,125 2024 Q3 13F Filing 2026-09-30 2026-11-16
GOSS
GOSSAMER BIO IN...
Healthcare 0.15% 0.11% #26 1
Prev: #27
0.1
—
-7,653,125 -98.8%
P
S
96,875 $1,147,969 2020 Q4 13F Filing 2026-09-30 2026-11-16
CNTX
CONTEXT THERAPE...
Healthcare 0.00% 0.15%
Sold All 😨
(Was: #26)
0.0
—
-3,050,000 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
SMMT
SUMMIT THERAPEU...
Healthcare 0.00% 1.64%
Sold All 😨
(Was: #17)
0.0
—
-1,250,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
ALMS
ALUMIS INC
Healthcare 0.00% 7.16%
Sold All 😨
(Was: #5)
0.0
—
-2,830,700 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-29 of 29 holdings

Unlock Full Octagon Capital Advisors LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →